218.29
+1.47
+(0.68%)
At close: April 11 at 6:18:20 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 19 | 25 | 25 |
| Avg. Estimate | 6.08B | 6.16B | 24.89B | 26.08B |
| Low Estimate | 5.99B | 5.84B | 23.73B | 23.51B |
| High Estimate | 6.31B | 6.37B | 25.52B | 27B |
| Year Ago Sales | 6.03B | 6.01B | 24.25B | 24.89B |
| Sales Growth (year/est) | 0.84% | 2.54% | 2.65% | 4.77% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0R2E.L | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | Raymond James: Strong Buy to Strong Buy | 4/11/2025 |
| Maintains | Jefferies: Hold to Hold | 4/9/2025 |
| Upgrade | Citigroup: Neutral to Buy | 4/8/2025 |
| Maintains | UBS: Neutral to Neutral | 4/2/2025 |
| Maintains | Susquehanna: Neutral to Neutral | 3/27/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/27/2025 |